80% of nuclear revenue comes from operating reactors today, not speculative newbuild timelines, anchoring growth in near-term cash conversion.
Mirion's revenue growth has stepped up from 5.0% in 2024Q2 to 24.5% in 2026Q3, reaching a $277.8M quarterly high, with the acquisition of a majority stake in 2025Q4 (approximately $581.3M net) appearing to underpin the acceleration.
Price trend, volume and key moving averages
Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 27, 2026 | $0.12-0.7% vs $0.12 | $278M+0.9% vs $275M |
Q3 2026 Jul 28, 2026 | $0.12+16.1% vs $0.10 | $267M-0.9% vs $269M |
Q2 2026 Apr 28, 2026 | $0.10+0.0% vs $0.10 | $258M+5.2% vs $245M |
Q1 2026 Feb 10, 2026 | $0.15-6.3% vs $0.16 | $277M-1.0% vs $280M |
80% of nuclear revenue comes from operating reactors today, not speculative newbuild timelines, anchoring growth in near-term cash conversion.
Extending the lifespans of current reactors creates compelling opportunities across the broader nuclear energy supply chain. While advanced reactor designs often capture headlines, the existing nuclear fleet represents significant current investment activity that is sometimes overlooked, Steffan Szumowski, nuclear research analyst at VettaFi, said during a recent webcast.

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Baird's 2026 Global Industrial Conference. The presentation will begin at 5:05 PM ET on Tuesday, November 10, 2026. The presentation will be webcast live at Mirion's Investor Relations Page where a webcast link will be displayed under the "Events and Presentations” section. An archive of the.
Mirion Technologies, Inc. ( MIR ) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDT Company Participants Eric Linn - Vice President of Investor Relations Thomas Logan - Founder, Medical Group President, CEO & Chairman Brian Schopfer - CFO & Medical Group President Conference Call Participants Tomohiko Sano - JPMorgan Chase & Co, Research Division Quinn Fredrickson - Robert W. Baird & Co. Incorporated, Research Division Joseph Ritchie - Goldman Sachs Group, Inc., Research Division Andrew Kaplowitz - Citigroup Inc. Exchange Research Nicholas Amicucci - Evercore ISI Institutional Equities, Research Division Jeffrey Grampp - Northland Capital Markets, Research Division Brandon Knutson - Morgan Stanley, Research Division James West - Melius Research LLC Presentation Operator Good day, everyone.
Benchmark MIR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Mirion Technologies, Inc. (MIR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $17.43 | $4.26B | 163.97 | 7.5% | 2.69% | 1.54% | — | |
| $197.02 | $3.25B | 20.17 | 4.25% | 8.79% | 18.92% | — | |
| $7.06 | $1.09B | -12.79 | 24.95% | -10.35% | -547.17% | — | |
| $23.75 | $3.86B | 6.12 | 8.32% | 22.01% | 20.52% | — | |
| $466.10 | $34.86B | 468.16 | 6.99% | 1.75% | 0.81% | — | |
| $53.94 | $12.57B | -80.07 | -2.61% | -4.08% | -2.91% | — |
Mirion Technologies, Inc. (MIR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Mirion Technologies, Inc. (MIR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 27, 2026·SEC
Jul 28, 2026·SEC
Jul 2, 2026·SEC
Get notified when MIR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Mirion Technologies, Inc. (MIR) stock FAQ — growth, dividends, profitability & financials explained
Mirion Technologies, Inc. (MIR) reported $1.08B in revenue over the trailing twelve months. Revenue was $925.4M in fiscal year 2025. That is 108% more than the $444.1M of fiscal year 2018.
Mirion Technologies, Inc. (MIR) grew revenue by 19.6% over the trailing twelve months, compared with the twelve months before.
Yes. Mirion Technologies, Inc. (MIR) earned $29.0M in net income over the trailing twelve months (a 2.7% net margin).
Mirion Technologies, Inc. (MIR) had a return on equity (ROE) of 1.5% over the trailing twelve months. That is below the market's typical 10-15%.
Mirion Technologies, Inc. (MIR) generated $171.1M in free cash flow over the trailing twelve months.